Form 4: Intuitive Surgical Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed a sale of company stock and stock options under a pre-arranged 10b5-1 trading plan.
Summary
- Robert DeSantis, an executive at Intuitive Surgical, sold 188 shares of common stock at $539 per share on November 29, 2024.
- He also exercised options to acquire 188 shares at $208.90 and 188 shares at $290.33, and then sold those shares at $539 per share on the same day.
- These transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
- The trading plan is set to expire on December 9, 2024.
- Following these transactions, Mr. DeSantis directly owns 5,506 shares of common stock and 2,820 non-qualified stock options at each of the two exercise prices.
Sentiment
Score: 5
Explanation: The document reflects a routine executive stock transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although this sale was under a pre-arranged plan.
Industry Context
Executive stock transactions are a normal part of corporate activity, and the use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading. This transaction is not unusual for a company of Intuitive Surgical's size and maturity.
Comparison to Industry Standards
- Executive stock sales are common across the technology and medical device industries.
- Companies like Medtronic, Stryker, and Johnson & Johnson also see regular insider transactions.
- The use of 10b5-1 plans is a standard practice for executives to manage their personal finances while avoiding potential conflicts of interest.
- The size of the transaction is relatively small compared to the overall market capitalization of Intuitive Surgical.
Stakeholder Impact
- The impact on shareholders is likely to be minimal, as the transaction was pre-planned and relatively small.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of stock and option transactions. |
| 12/02/2024 | Date of filing of the SEC Form 4. |
| 12/09/2024 | Expiration date of the 10b5-1 trading plan. |
| 02/28/2029 | Expiration date of one set of non-qualified stock options. |
| 08/28/2029 | Expiration date of another set of non-qualified stock options. |
Keywords
Intuitive Surgical, ISRG, Robert DeSantis, stock sale, 10b5-1 trading plan, executive stock options, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.